Skip to main content
. 2021 Mar 23;29(10):5865–5872. doi: 10.1007/s00520-021-06056-5

Table 1.

Comparison of demographic and clinical characteristics in the control and intervention groups

Control group (N %) Intervention group (N %) P valuea
Gender Males 21 (70) 13 (43.3) 0.067
Females 9 (30) 17 (56.7)
Marital status Single 4 (13.3) 6 (20) 0.825
Married 23 (76.7) 22 (73.3)
Widow 3 (10) 2 (6.7)
Educational level Illiterate 6 (20) 4 (13.3) 0.217
Primary 15 (50) 8 (26.7)
Guidance 3 (10) 4 (13.3)
High school 3 (10) 8 (26.7)
Academic 3 (10) 6 (20)
Type of cancer Liver 0 2 (6.7) 0.057
Breast 1 (3.3) 8 (26.7)
CML 3 (10) 0
Lymphomas 1 (3.3) 5 (16.7)
CRC 5(16.7) 3 (10)
ALL 3 (10) 1 (3.3)
Lung 3 (10) 2 (6.7)
Esophagus 2 (6.7) 0
Gastric 3 (10) 1 (3.3)
Prostate 2 (6.7) 1 (3.3)
Bone marrow 1 (3.3) 0
Small intestine 0 1 (3.3)
AML 2 (6.7) 3 (10)
Sarcoma 1 (3.3) 1 (3.3)
Thyroid 0 1 (3.3)
Brain 1 (3.3) 1 (3.3)
Pancreatic 2 (6.7) 0
Age (years) Mean (SD) Mean (SD) P valueb
54.66 (17.09) 47.93 (17.44) 0.137
Time from diagnosis (years) 1.93 (1.85) 2.54 (2.85) 0.333
Chemotherapy course 8.7 (8.25) 4.83 (3.24) 0.02

aChi-square and Fisher’s exact tests

bt-test

CML chronic myelogenous leukemia, CRC colorectal cancer, AML acute myeloid leukemia